Kestra Medical Technologies (KMTS) Competitors $16.56 +0.44 (+2.73%) As of 11:29 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KMTS vs. LIVN, INSP, WRBY, LQDA, PRCT, LMAT, AORT, EYE, ENOV, and CNMDShould you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include LivaNova (LIVN), Inspire Medical Systems (INSP), Warby Parker (WRBY), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), Enovis (ENOV), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. Kestra Medical Technologies vs. Its Competitors LivaNova Inspire Medical Systems Warby Parker Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion National Vision Enovis CONMED LivaNova (NASDAQ:LIVN) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings. Does the media favor LIVN or KMTS? In the previous week, LivaNova had 1 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 9 mentions for LivaNova and 8 mentions for Kestra Medical Technologies. LivaNova's average media sentiment score of 1.52 beat Kestra Medical Technologies' score of 0.92 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Kestra Medical Technologies 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in LIVN or KMTS? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, LIVN or KMTS? LivaNova has higher revenue and earnings than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.25B2.43$63.23M-$3.89-14.34Kestra Medical Technologies$59.81M14.22-$113.81MN/AN/A Is LIVN or KMTS more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Kestra Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets LivaNova-16.13% 14.57% 6.91% Kestra Medical Technologies N/A N/A N/A Do analysts prefer LIVN or KMTS? LivaNova currently has a consensus target price of $59.71, suggesting a potential upside of 7.02%. Kestra Medical Technologies has a consensus target price of $27.33, suggesting a potential upside of 65.06%. Given Kestra Medical Technologies' higher probable upside, analysts clearly believe Kestra Medical Technologies is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummaryLivaNova beats Kestra Medical Technologies on 10 of the 14 factors compared between the two stocks. Get Kestra Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KMTS vs. The Competition Export to ExcelMetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$850.36M$10.63B$5.76B$9.85BDividend YieldN/A1.84%6.66%4.48%P/E RatioN/A21.5782.2726.62Price / Sales14.2230.99534.88109.99Price / CashN/A25.1325.7028.92Price / Book4.143.4510.816.59Net Income-$113.81M$211.94M$3.28B$265.93M7 Day Performance-8.00%-0.70%0.23%-0.26%1 Month Performance7.67%13.14%10.66%6.61%1 Year PerformanceN/A-7.14%51.27%22.69% Kestra Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KMTSKestra Medical Technologies1.3644 of 5 stars$16.56+2.7%$27.33+65.1%N/A$850.36M$59.81M0.00300News CoveragePositive NewsLockup ExpirationLIVNLivaNova1.7309 of 5 stars$56.34+1.6%$59.71+6.0%+13.0%$3.08B$1.31B-14.482,900News CoveragePositive NewsAnalyst ForecastINSPInspire Medical Systems4.9942 of 5 stars$93.86+2.6%$165.62+76.4%-47.4%$2.78B$861.31M54.261,246Positive NewsAnalyst ForecastInsider TradeWRBYWarby Parker1.7707 of 5 stars$26.16-0.3%$24.06-8.0%+71.6%$2.75B$821.35M-373.723,780Positive NewsLQDALiquidia Technologies3.3061 of 5 stars$27.67+0.8%$32.11+16.1%+200.5%$2.38B$14M-16.2750Trending NewsInsider TradeOptions VolumePRCTPROCEPT BioRobotics3.6713 of 5 stars$40.31-0.1%$74.88+85.8%-49.9%$2.24B$224.50M-26.01430Positive NewsAnalyst UpgradeLMATLeMaitre Vascular3.03 of 5 stars$95.41+0.1%$97.60+2.3%+5.2%$2.16B$219.86M46.32490Positive NewsAORTArtivion3.3075 of 5 stars$43.87+0.1%$40.63-7.4%+60.9%$2.07B$405.04M-104.451,600EYENational Vision3.6044 of 5 stars$22.92-2.1%$24.73+7.9%+107.8%$1.82B$1.82B-127.3313,411Positive NewsENOVEnovis4.3714 of 5 stars$30.88+1.0%$51.00+65.1%-33.7%$1.77B$2.19B-2.177,367Positive NewsCNMDCONMED4.6079 of 5 stars$54.34+1.1%$59.80+10.0%-27.0%$1.68B$1.33B15.393,900Positive News Related Companies and Tools Related Companies LIVN Alternatives INSP Alternatives WRBY Alternatives LQDA Alternatives PRCT Alternatives LMAT Alternatives AORT Alternatives EYE Alternatives ENOV Alternatives CNMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KMTS) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
